-
Pol II Degradation and Transcription-Independent Death
2026-08-11
The preprint argues that targeted degradation of RNA polymerase II can activate cell death without requiring global transcriptional shutdown, separating Pol II loss from the conventional assumption that death follows transcriptional collapse. This distinction provides a useful framework for interpreting apoptosis mechanisms and for designing experiments that independently measure protein degradation, transcription, and cell-death execution.
-
Entinostat (MS-275) Workflow for Cancer Assays
2026-08-10
Entinostat (MS-275) combines HDAC1/3-biased epigenetic modulation with a practical platform for separating growth arrest from true cell killing. This workflow shows how to optimize dosing, pair viability with death and acetylation readouts, and translate findings cautiously into retinoblastoma research and solid tumor studies.
-
JNJ-26854165 (Serdemetan): p53 Research Guide
2026-08-09
JNJ-26854165, also called Serdemetan, is a small-molecule HDM2 ubiquitin ligase antagonist for preclinical cancer research. Its reported activity includes p53 pathway modulation, cell-proliferation inhibition, endothelial migration inhibition, and enhancement of radiation-induced tumor growth delay in xenografts.
-
Cy3 TSA Fluorescence System Kit Workflow
2026-08-08
Build a sensitive, microscopy-ready workflow for IHC, ICC, and ISH when conventional fluorescence produces weak or ambiguous signals. This guide connects Cy3 tyramide deposition with spatial proteomics, showing where the kit adds localization confidence and where it should not be mistaken for a proteomic measurement.
-
Primidone Workflows for TRPM3 and RIPK1
2026-08-07
Primidone (Mysoline) offers a practical bridge between TRPM3 channel assays and RIPK1-centered neurodegeneration research. This guide converts its biochemical profile into reproducible cell, animal, and biomarker workflows, with dosing logic and troubleshooting for translational studies.
-
MDM1 Overexpression Sensitizes Colorectal Cancer to Chemorad
2026-08-07
The referenced study establishes MDM1 as a key regulator of p53-mediated apoptosis, enhancing chemoradiotherapy sensitivity in colorectal cancer. These findings provide mechanistic insight and position MDM1 as a predictive biomarker and potential intervention target for overcoming treatment resistance.
-
Myriocin as a Precision Tool: Advancing Sphingolipid Metabol
2026-08-06
Explore the multifaceted roles of Myriocin, a potent serine palmitoyltransferase inhibitor, in sphingolipid metabolism research. This article uniquely dissects its systemic impact on metabolic homeostasis, offering critical insights for advanced assay design.
-
VX-765: Precision Caspase-1 Inhibition for Translational Dis
2026-08-06
Explore how VX-765, a selective caspase-1 inhibitor, empowers advanced translational disease models by enabling precise modulation of IL-1β and IL-18 release. This article uniquely bridges mitochondrial apoptotic pathways with practical assay design, offering actionable guidance for inflammation and pyroptosis research.
-
Caspase-8 Fluorometric Assay Kit: Precision in Apoptosis Ass
2026-08-05
Unlock sensitive, quantitative detection of Caspase-8 activity with APExBIO’s Caspase-8 Fluorometric Assay Kit. This guide connects mechanistic advances in cell death research to stepwise protocols, advanced applications, and troubleshooting strategies, empowering apoptosis and neurodegenerative disease studies.
-
Panobinostat (LBH589): Driving Epigenetic-Driven Synergy in
2026-08-05
Explore how Panobinostat (LBH589), a potent HDAC inhibitor, enables breakthrough synergy in epigenetic regulation research and advanced cancer model systems. Discover mechanistic insights and practical guidance not found in standard protocols.
-
Calpeptin: Calpain Inhibitor Workflows for Fibrosis Modulati
2026-08-04
Calpeptin empowers researchers with nanomolar-precision inhibition of calpain, enabling advanced studies in pulmonary fibrosis and inflammation. This article delivers actionable protocols, troubleshooting strategies, and practical insights to maximize Calpeptin’s impact in translational disease models.
-
Netarsudil (AR-13324): Predictive Chemistry for siRNA Codeli
2026-08-04
Explore how Netarsudil (AR-13324) unlocks predictive, high-efficiency siRNA codelivery via advanced molecular modeling, enabling next-generation nanoparticle therapeutics. Discover mechanistic insights and practical guidance for innovative research.
-
Z-YVAD-FMK: Selective Caspase-1 Inhibitor for Pyroptosis Res
2026-08-03
Z-YVAD-FMK is a cell-permeable, irreversible caspase-1 inhibitor that blocks IL-1β and IL-18 release by covalently modifying the caspase-1 active site. Its selectivity and efficacy are validated in both in vitro and in vivo models, making it a pivotal tool for pyroptosis and inflammasome activation studies.
-
Tirbanibulin Suppresses HPV Oncogenic Pathways in HeLa Cells
2026-08-03
This study demonstrates that tirbanibulin, an antiproliferative agent, significantly decreases cell proliferation and downregulates key oncogenic and HPV-related protein pathways in HeLa cells. The findings clarify tirbanibulin's multifaceted impact on HPV-driven cancer cell signaling, suggesting new research avenues for therapeutic targeting in HPV-associated malignancies.
-
Sulforaphane Reduces NLRP3 Inflammasome Activity in Colitis
2026-08-02
This reference study elucidates how sulforaphane, a naturally occurring isothiocyanate, mitigates ulcerative colitis in mice by suppressing oxidative stress and inhibiting NLRP3 inflammasome activation. These findings advance mechanistic understanding of inflammasome-driven inflammation, supporting sulforaphane's application in preclinical inflammatory bowel disease research.